Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benfotiamine for Diabetic Polyneuropathy
NCT01868191Phase 3Unknown
- Start
- Jul 2013
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of benfotiamine in diabetic sensorimotor polyneuropathy (DSPN). Status: unknown.
02
Drugs
benfotiamine
03
Conditions
diabetic sensorimotor polyneuropathy (DSPN)
Beyond the preview
Go deeper on NCT01868191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868191.